Medici: Announcement on participating in the 2024 Semi-Annual Science and Technology Innovation Board Special Group Performance Briefing on Pharmaceuticals and Biological Products
Guangfa Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Shanghai Medici Biomedical Co., Ltd.
Medici: Progress Announcement on the Repurchase of Company Shares through Centralized Bidding
Shanghai Medicilon Inc.: Investor Relations Activity Record (2024-08-001)
GF SEC's verification opinion on Shanghai Medicilon Inc. using part of the idle raised funds for cash management.
Shanghai Medicilon Inc.: Announcement regarding the use of temporarily idle funds raised for cash management.
Shanghai Medicilon Inc.: Half-year evaluation report of the "Quality Improvement and Efficiency Increase for Return" action plan for the year 2024.
Shanghai Medicilon Inc.: Special report on the use and placement of funds raised during the first half of 2024.
Shanghai Medicilon Inc.: Half-year report for the year 2024.
Shanghai Medicilon Inc.: Summary of Half-Year Report in 2024.
Shanghai Medicilon Inc.: Announcement of the Resolution of the 20th Meeting of the 3rd Supervisory Board.
Shanghai Medicilon Inc.: Announcement on the progress of repurchasing the company's shares through centralized bidding trade.
Shanghai Medicilon Inc.: Investor relations activity record (2024-07-002)
Shanghai Medicilon Inc.: Investor Relations Activity Record Form (2024-07-001)
Shanghai Medicilon Inc.: Announcement on the progress of repurchasing the company's shares through centralized bidding trade.
Reply to the regulatory inquiry letter on information disclosure of the annual report of Shanghai Medicilon Inc. for the year 2023 by Ruihua Certified Public Accountants (Special General Partnership).
Shanghai Medicilon Inc.: Announcement of Reply to Information Disclosure Inquiry Letter on 2023 Annual Report Regulation.
Shanghai Medicilon Inc.: Announcement on the progress of repurchasing the company's shares through centralized bidding trade.
Shanghai Medicilon Inc.: Announcement regarding the judicial freeze of a portion of the shareholder's shares.
Shanghai Medicilon Inc.: Announcement on the initial repurchase of the company's shares through centralized bidding transactions and the progress of the repurchase
No Data